AADR vs. SBIO ETF Comparison

Comparison of WCM BNY Mellon Focused Growth ADR ETF (AADR) to ALPS Medical Breakthroughs ETF (SBIO)
AADR

WCM BNY Mellon Focused Growth ADR ETF

AADR Description

The investment seeks long-term capital appreciation above international benchmarks such as the BNY Mellon Classic ADR Index, the fund's primary benchmark, and the MSCI EAFE Index, the fund's secondary benchmark. The sub-advisor seeks to achieve the fund's investment objective by selecting primarily a portfolio of U.S.-traded securities of non-U.S. organizations, most often American Depositary Receipts ("ADRs"), included in the BNY Mellon Classic ADR Index. The fund's investment focus follows the Sub-Advisor's core philosophy of investing in industry-leading non-U.S. organizations led by visionary management teams with sound business strategies.

Grade (RS Rating)

Last Trade

$67.45

Average Daily Volume

894

Number of Holdings *

26

* may have additional holdings in another (foreign) market
SBIO

ALPS Medical Breakthroughs ETF

SBIO Description The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.

Grade (RS Rating)

Last Trade

$37.20

Average Daily Volume

8,661

Number of Holdings *

83

* may have additional holdings in another (foreign) market
Performance
Period AADR SBIO
30 Days 2.78% -5.42%
60 Days 6.23% -4.09%
90 Days 8.46% 0.49%
12 Months 30.70% 48.12%
1 Overlapping Holdings
Symbol Grade Weight in AADR Weight in SBIO Overlap
VRNA B 2.9% 1.98% 1.98%
AADR Overweight 25 Positions Relative to SBIO
Symbol Grade Weight
YPF B 6.36%
GGAL B 5.56%
NVO F 4.85%
BMA C 4.69%
ERJ A 4.36%
PAM A 3.96%
ABBV F 3.64%
MUFG B 3.6%
QFIN A 3.05%
SAP B 3.04%
BCS A 2.74%
RELX D 2.72%
BBVA D 2.68%
MELI C 2.68%
SE A 2.63%
ERIC C 2.58%
SMFG B 2.54%
HMY D 2.49%
TSM B 2.36%
ING F 2.13%
TEVA C 2.13%
CHKP C 2.09%
NVS F 2.03%
FUTU D 1.79%
TCOM B 1.74%
AADR Underweight 82 Positions Relative to SBIO
Symbol Grade Weight
CORT B -3.66%
KRYS C -3.39%
RNA C -3.29%
ACLX C -3.19%
ALKS C -3.15%
CRNX C -2.95%
IMVT F -2.66%
DNLI D -2.36%
MRUS F -2.21%
AGIO C -2.05%
PTCT B -2.02%
XENE D -2.01%
FOLD F -1.95%
EWTX C -1.92%
ACAD C -1.89%
VERA C -1.82%
ZLAB C -1.79%
VCEL B -1.73%
PTGX D -1.61%
CGON F -1.57%
IDYA F -1.53%
GERN D -1.48%
MIRM B -1.47%
KROS D -1.4%
LBPH A -1.4%
AKRO B -1.32%
MNKD C -1.26%
IRON B -1.21%
GLPG F -1.19%
TARS C -1.16%
IMCR D -1.07%
CLDX F -1.06%
ARVN F -1.06%
BCRX D -0.99%
XNCR B -0.98%
RCUS F -0.95%
NTLA F -0.94%
SNDX F -0.93%
SPRY C -0.88%
VRDN D -0.84%
KURA F -0.83%
DAWN D -0.82%
AUPH B -0.78%
PHVS C -0.76%
APLT C -0.72%
COGT D -0.69%
ETNB C -0.57%
LQDA F -0.54%
PLRX D -0.53%
PRTA F -0.52%
ERAS C -0.51%
REPL D -0.5%
IRWD F -0.44%
AVXL B -0.42%
ANNX F -0.4%
MLYS F -0.39%
ALT C -0.37%
OLMA F -0.37%
ANAB F -0.36%
FLGT F -0.35%
ALLO F -0.35%
CELC F -0.34%
YMAB F -0.34%
URGN F -0.34%
SVRA F -0.34%
FULC F -0.33%
TBPH B -0.32%
FDMT F -0.31%
GHRS C -0.31%
ARCT F -0.31%
AURA C -0.3%
ALEC F -0.28%
CMPS F -0.23%
ACIU D -0.22%
VNDA C -0.2%
ITOS F -0.19%
STRO F -0.17%
ALDX D -0.17%
ZNTL F -0.17%
ENTA F -0.14%
INZY F -0.12%
HLVX F -0.06%
Compare ETFs